Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations
Open Access
- 26 September 2017
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 117 (11) , 1685-1688
Abstract
The clinical presentation of patients with hepatitis C virus (HCV)-positive diffuse large B-cell lymphoma (DLBCL) is different from their HCV-negative counterparts, but the underlying molecular and pathological characteristics are largely under investigated. The virus has a role in lymphomagenesis, as witnessed by the curative potential of antiviral therapy in HCV-related low-grade B-cell lymphomas. We performed a case-control study including 44 HCV-positive cases of de novo DLBCL, comparing them with 132 HCV-negative patients as controls (ratio 3 to 1). Cases and controls were matched for age, lactate dehydrogenase level and international prognostic index at presentation. Patients were studied by gene expression profiling for cell-of-origin determination and to perform differential expression analysis between groups, fluorescence in-situ hybridisation and immunohistochemistry for MYC, BCL2 and BCL6, TP53 mutations, and diagnostic specimens reviewed to exclude transformation from low-grade lymphoma. Compared to the HCV-negative controls, patients with HCV-positive de novo DLBCL had differential expression of genes that regulate innate immune response and modulate apoptotic pathways, have higher proliferative index, and lack BCL2 translocations. HCV-positive DLBCL have distinct molecular and pathological features compared to the HCV-negative counterparts.Keywords
This publication has 15 references indexed in Scilit:
- Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infectionBlood, 2016
- The 2016 revision of the World Health Organization classification of lymphoid neoplasmsBlood, 2016
- The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infectionHaematologica, 2014
- Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological studyLaboratory Investigation, 2014
- Lymphomas occurring specifically in HIV-infected patients: From pathogenesis to pathologySeminars in Cancer Biology, 2013
- Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana LinfomiHaematologica, 2013
- Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical managementJournal of Hepatology, 2013
- Hepatic toxicity and prognosis in hepatitis C virus–infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysisBlood, 2010
- Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway #Hepatology, 2009
- Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control studyBlood, 2003